Company Overview
Snapshot
Founded in August 2009 by Yohai Golan-Gild, Better operates with 11–50 employees. The company has raised $15 million across one funding round from Narin Niruttinanon. In February 2022, InterCure signed a definitive agreement to acquire Better, signaling a significant strategic move within the medical cannabis industry.
Business overview
Better specializes in the development of medical-grade cannabis for various medical conditions, focusing on strains with diverse CBD and THC combinations and high terpene levels to enhance product efficiency and potency. The company offers a range of standardized and stable natural medicines, grown by experts, guaranteed to contain consistent levels of active pharmaceutical ingredients. Better has developed eight unique strains, with more in development, providing a wide array of cannabinoid and terpene combinations to address specific medical needs. It operates within the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology and Medical Cannabis, serving the healthcare industry and patients globally, including Australia.
Strategic signal
In February 2022, InterCure signed a definitive agreement to acquire Better, a multi-national medical cannabis producer. This acquisition indicates a consolidation trend within the medical cannabis market and validates Better's product development and market position, suggesting a strategic expansion for InterCure and a new phase for Better under a larger entity.
Log in to access full profile ›Company Intelligence Q&A
- What was a significant corporate development for Better in early 2022?
- In February 2022, InterCure signed a definitive agreement to acquire Better, a multi-national medical cannabis producer.
- When did Better Holdings express interest in selling its Israeli operations?
- In October 2019, Cannabis Company Better Holdings indicated its intention to sell its Israeli operations.
- Who was identified as an investor in Better in June 2020?
- In June 2020, Thai businessman Narin Niruttinanon was identified as an investor in the Israeli cannabis company Better.
- What was the focus of Better's founder in advancing medicinal marijuana research?
- In September 2016, Better Founder Yohai Gild Golan was noted for advancing medicinal marijuana research in Israel.
- What medical cannabis trial was announced in June 2016 involving the University of Canberra?
- In June 2016, medical cannabis was announced to be trialled in the treatment of melanoma at the University of Canberra.